Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.20 | -2.61% | 231.20 | 231.00 | 231.40 | 236.80 | 229.60 | 232.40 | 19,138,183 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.29B | 190.5M | 0.0929 | 24.89 | 4.87B |
Convatec Group PLC (CTEC) Convatec Group PLC: Results of 2022 AGM - Update Statement 23-Sep-2022 / 14:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
23 September 2022
Convatec Group Plc ("Convatec" or "the Company")
Results of 2022 AGM - Update Statement
While the Resolution to approve the Directors' Remuneration Report at the last AGM was passed, we acknowledge that a number of shareholders chose not to support this Resolution.
Prior to the AGM the Remuneration Committee consulted extensively with shareholders and following the AGM, the Remuneration Committee Chair wrote to our largest shareholders who voted against the Resolution to understand their reasons and to offer further engagement.
The Remuneration Committee is committed to positive engagement with shareholders and will be consulting further over the coming months in respect of the Company's forthcoming Remuneration Policy review.
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, Convatec +44 (0)782 644 7807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane ?????? ? +44 (0)207 466 5000 ???????????????? ????????????????????????
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 250 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over USD2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http:// www.convatecgroup.com
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD3VFW73 Category Code: AGM TIDM: CTEC LEI Code: 213800LS272L4FIDOH92 Sequence No.: 189992 EQS News ID: 1448703 End of Announcement EQS News Service =------------------------------------------------------------------------------------
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1448703&application_name=news
(END) Dow Jones Newswires
September 23, 2022 09:00 ET (13:00 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions